Clinical Trials Browser

INDUSTRY × Interventional × Inflammatory Bowel Diseases × Clear all

NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Phase 4 Completed

1 enrolled 1 chart

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

NCT04633512 2024-02-21

Safety and Feasibility of ActivSightTM in Human

Phase NA Unknown

GastrointestinalOther

Diverticulitis, Colonic, Obesity, Morbid, Colorectal Neoplasms, Inflammatory Bowel Diseases, Cholecystitis, Acute

NCT06055543 2023-09-26

Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients

Phase 4 Unknown

Acquired Immunodeficiency Syndrome, Neoplasms, Inflammatory Bowel Diseases, Pulmonary Disease, Chronic Obstructive, Malnutrition

NCT01714726 2021-05-26

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Phase 2 Completed

121 enrolled 22 charts

Crohn Disease, Inflammatory Bowel Diseases

NCT02574637 2021-05-26

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Phase 2 Terminated

29 enrolled 25 charts

Crohn Disease, Inflammatory Bowel Diseases

NCT01369329 2016-12-07

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Phase 3 Completed

769 enrolled 13 charts

Colitis, Crohn Disease, Inflammatory Bowel Diseases